FDA.reportPublic FDA data

Antiperspirant ODABAN

Manufacturer
Ryma-Pharm GmbH
Effective date
2025-12-15
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:23:08

Label at a glance#

ProductAntiperspirant ODABAN
Active ingredientALUMINUM CHLORIDE
Label structure8 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

ODABAN® Antiperspirant Spray is a safe and simple antiperspirant that protects against excessive sweating and odour. Up to 90% sweat reduction after only 3 applications. Caution: Do not spray in eyes or apply to irritated skin. Avoid contact with clothing.

WARNINGS SECTION

Warnings For external use only Do not use on broken skin Stop use if rash or irritation occurs Ask a doctor before use if you have kidney disease Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center

INACTIVE INGREDIENT SECTION

Inactive Ingredients Aqua, Pentylene Glycol, 1,2-Heptanediol

INDICATIONS & USAGE SECTION

Directions Apply at bedtime. Ensure skin is clean and dry. Use only one pump per armpit or body area.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center.

OTC - PURPOSE SECTION

Uses Decreases excessive sweating

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient Aluminium Chloride 14,5%

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Content of LabelingContent of LabelingDrug Facts Active Ingredient Aluminium Chloride 14,5% ODABAN® Antiperspirant Spray is a safe and simple antiperspirant that protects against excessive sweating and odour. Up to 90% sweat reduction after only 3 applications. Caution: Do not spray in eyes or apply to irritated skin. Avoid contact with clothing. Made in Germany by: RYMA PHARM GmbH, An der Eiche 14, 34327 Körle, Germany Made for: Archifox GmbH & Co. KG, Im Kitzwinkel 2, 34327 Körle, Germany Filling height Inactive Ingredients Aqua, Pentylene Glycol, 1,2-Heptanediol Purpose Antiperspirant Questions Call +1 (646) 566-6506 Directions Apply at bedtime. Ensure skin is clean and dry. Use only one pump per armpit or body area. Uses Decreases excessive sweating Warnings For external use only Do not use on broken skin Stop use if rash or irritation occurs Ask a doctor before use if you have kidney disease Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84788-0001-1Antiperspirant ODABAN30 mL in 1 BOTTLE, SPRAYSPRAY302

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84788-000184788-0001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
AQUA REGIAX3TT5X989EIACT
PENTYLENE GLYCOL50C1307PZGIACT
(6R)-2-METHYL-6-((1R,3AS,4E,7AR)-OCTAHYDRO-4-((2Z)-2-((5S)-5-HYDROXY-2-METHYLENECYCLOHEXYLIDENE)ETHYLIDENE)-7A-METHYL-1H-INDEN-1-YL)-2,4-HEPTANEDIOLUH3E0E5N53IACT
ALUMINUM CHLORIDE3CYT62D3GAACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Antiperspirant ODABANSPRAY ANTIPERSPIRANT ODABANRyma-Pharm GmbH231930da-93d9-46d3-e063-6394a90a3fdd2025-12-15WarningsExact identifier
ndc (package): 84788-0001-1
ndc (product): 84788-0001
ndc11 (package): 84788000101
spl id: 46020ccd-0eda-9dcd-e063-6294a90a23be
spl set id: 231930da-93d9-46d3-e063-6394a90a3fdd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.